Want to see SLXN full AI Analyst Report?
Silexion Therapeutics (SLXN) Ownership - Who Owns Silexion Therapeutics?
247 Followers
Silexion Therapeutics (SLXN) Ownership Overview
- 3.78% Insiders
- 1.48% Other Institutional Investors
- 94.73% Public Companies and Individual Investors
The ownership structure of Silexion Therapeutics (SLXN) stock is a mix of institutional, retail, and individual investors. Approximately 1.48% of the company’s stock is owned by Institutional Investors, 3.78% is owned by Insiders, and 94.73% is owned by Public Companies and Individual Investors.
The ownership structure of Silexion Therapeutics (SLXN) stock is a mix of institutional, retail, and individual investors. Approximately 1.48% of the company’s stock is owned by Institutional Investors, 3.78% is owned by Insiders, and 94.73% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Mar 29, 2026 | Mitchell Shirvan | $31,032 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Ilan Levin | 458,452 | Insider | 3.01% | 70,143 |
| Shlomo Noy | 25,399 | Insider | 0.17% | 3,886 |
| Avner Lushi | 25,399 | Insider | 0.17% | 3,886 |
| Ilan Hadar | 16,547 | Insider | 0.11% | 2,532 |
| Hadar Mirit Horenshtein | 12,515 | Insider | 0.08% | 1,915 |
| Ruth Alon | 10,228 | Insider | 0.07% | 1,565 |
| Dror Yosef Abramov | 10,180 | Insider | 0.07% | 1,558 |
| Mitchell Shirvan | 8,789 | Insider | 0.06% | 1,345 |
| Amnon Peled | 8,237 | Insider | 0.05% | 1,260 |
FAQ
Who Owns Silexion Therapeutics (SLXN)?
According to the latest TipRanks data, approximately 1.48% of the company's stock is held by institutional investors, 3.78% is held by insiders, and 94.73% is held by public companies and individual investors.
What percentage of Silexion Therapeutics (SLXN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.48% of Silexion Therapeutics (SLXN) stock is held by institutional investors.
What percentage of Silexion Therapeutics (SLXN) stock is held by retail investors?
According to the latest TipRanks data, approximately 94.73% of Silexion Therapeutics (SLXN) stock is held by public companies and individual investors.
Who owns the most shares of Silexion Therapeutics (SLXN)?
Ilan Levin owns the most shares of Silexion Therapeutics (SLXN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
